SDX-3103 Kick-Off Meeting, Biel

SynDermix announces the successful kick-off meeting of the project SDX-3103, a proprietary medical device for the treatment and prevention of ...

Read More

Share capital increased

The Board of Directors announce a successful increase of share capital: A total of CHF 5 394 135.96 in loans ...

Read More

AGM 2018: Election of New Chairman and Board of Directors

SynDermix announces the election of a new Chairman and Board of Directors at the Annual General Meeting of 2018.   ...

Read More